Ó£»¨ÊÓÆµ

Skip to main content

Table 2 Comorbidities of fracture patients and non-fracture individuals

From: Top comorbidities in osteoporotic fracture patients in a northeast population in China

Ranka

Comorbidity

Fracture patients

Non-fracture individuals

Pb

Pc

Pd

Overall

Community-based

Hospital-based

1

Hyperlipidemia

NA

117 (63.6)

NA

179 (49.4)

NA

0.001

NA

2

Hypertension

105 (45.3)

85 (47.0)

20 (39.2)

204 (56.4)

0.326

0.040

0.008

3

Type 2 diabetes

60 (25.9)

45 (24.9)

15 (29.4)

108 (29.8)

0.512

0.230

0.294

4

CHD

46 (19.8)

33 (18.2)

13 (25.5)

42 (11.6)

0.251

0.032

0.006

5

Obesity

43 (18.5)

39 (21.5)

4 (7.8)

75 (20.7)

0.026

0.824

0.515

6

Osteoporosis

28 (12.1)

13 (7.2)

15 (29.4)

1 (0.3)

&±ô³Ù; 0.001

0.002

&±ô³Ù; 0.001

7

Stroke

20 (8.6)

11 (6.1)

9 (17.6)

4 (1.1)

0.021

0.004

&±ô³Ù; 0.001

8

Rheumatoid arthritis

16 (6.9)

13 (7.2)

3 (5.9)

4 (1.1)

0.991

0.001

&±ô³Ù; 0.001

9

Gastrointestinal

7 (3.0)

4 (2.2)

3 (5.9)

0

0.373

0.024

0.001

10

Respiratory diseases

6 (2.6)

2 (1.1)

4 (7.8)

0

0.022

0.221

0.003

11

Hyperthyroidism

4 (1.7)

3 (1.7)

1 (2.0)

0

0.883

0.073

0.023

12

Breast cancer

1 (0.6)

1 (0.8)

0

1 (0.4)

0.583

0.624

0.758

13

Hyperparathyroidism

1 (0.4)

1 (0.6)

0

0

0.595

0.667

0.391

  1. Values are shown as n (%). CHD: coronary heart disease; Gastrointestinal: gastrointestinal diseases; NA: Not applicable. Ranka was based on the comorbidity prevalence (except for hyperlipidemia) order of overall fracture patients. Pb indicates the significance level between community- and hospital-based fracture patients; Pc indicates the significance level between community-based fracture patients and non-fracture individuals; Pd indicates the significance level between overall fracture patients and non-fracture individuals